When the economy is barreling toward a recession, investors' first line of defense might be to abandon ship altogether. After ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive. But when a dividend yield ...

Pfizer's 5.7% dividend yield, while attractive, raises significant sustainability concerns. The company's payout ratio has skyrocketed to 436%, ...

Pfizer Declares Third-Quarter 2025 Dividend. Board of Directors approves quarterly cash dividend of $0.43 per share. Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a ...

That said, Pfizer Inc. (NYSE:PFE) has a five-year average payout ratio above 101%, which may seem alarming at first. A company can’t consistently pay more in dividends than it earns.